TrialPharmacology research & perspectives2024

Effectiveness of edaravone in preventing contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A randomized, double-blind trial.

Azam Esmailnejad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.